120 related articles for article (PubMed ID: 36300501)
1. Computational approaches for innovative anti-viral drug discovery using
Zaib S; Akram F; Waris W; Liaqat ST; Zaib Z; Khan I; Dera AA; Pashameah RA; Alzahrani E; Farouk AE
J Biomol Struct Dyn; 2023; 41(18):8738-8750. PubMed ID: 36300501
[TBL] [Abstract][Full Text] [Related]
2. Discovery of azaleatin as a potential allosteric inhibitor for dengue NS2B-NS3 protease using
Mustafa NF; Cheng KK; Nadri MH; Razali SA; Zakaria II; Salin NH; Amran SI
J Biomol Struct Dyn; 2024 Jun; ():1-12. PubMed ID: 38881303
[TBL] [Abstract][Full Text] [Related]
3. Computer-aided identification of dengue virus NS2B/NS3 protease inhibitors: an integrated molecular modelling approach for screening of phytochemicals.
Mufti IU; Sufyan M; Shahid I; Alzahrani AR; Shahzad N; M Alanazi IM; Ibrahim IAA; Rehman S
J Biomol Struct Dyn; 2023 Sep; ():1-12. PubMed ID: 37747078
[TBL] [Abstract][Full Text] [Related]
4. Effect of mutation of NS2B cofactor residues on Dengue 2 NS2B-NS3 protease complex - an insight to viral replication.
Mohanty AK; Kumar MS
J Biomol Struct Dyn; 2023 Feb; 41(2):493-510. PubMed ID: 34871140
[TBL] [Abstract][Full Text] [Related]
5. Lead Optimization Studies Towards Finding NS2B/NS3 Protease Targetspecific Inhibitors as Potential Anti-dengue Drug-like Compounds.
Gurusamy M; Abdul JF
Curr Drug Discov Technol; 2019; 16(3):307-314. PubMed ID: 29984660
[TBL] [Abstract][Full Text] [Related]
6. Antiviral phytochemicals as potent inhibitors against NS3 protease of dengue virus.
Rahman MM; Biswas S; Islam KJ; Paul AS; Mahato SK; Ali MA; Halim MA
Comput Biol Med; 2021 Jul; 134():104492. PubMed ID: 34022487
[TBL] [Abstract][Full Text] [Related]
7. Structure-guided screening of chemical database to identify NS3-NS2B inhibitors for effective therapeutic application in dengue infection.
Bhowmick S; Alissa SA; Wabaidur SM; Chikhale RV; Islam MA
J Mol Recognit; 2020 Jul; 33(7):e2838. PubMed ID: 32060998
[TBL] [Abstract][Full Text] [Related]
8. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
Purohit P; Sahoo S; Panda M; Sahoo PS; Meher BR
J Mol Model; 2022 Oct; 28(11):365. PubMed ID: 36274116
[TBL] [Abstract][Full Text] [Related]
9. Phytochemical Compound Screening to Identify Novel Small Molecules against Dengue Virus: A Docking and Dynamics Study.
Shimu MSS; Mahmud S; Tallei TE; Sami SA; Adam AA; Acharjee UK; Paul GK; Emran TB; Zaman S; Uddin MS; Saleh MA; Alshehri S; Ghoneim MM; Alruwali M; Obaidullah AJ; Jui NR; Kim J; Kim B
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163918
[TBL] [Abstract][Full Text] [Related]
10. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
[TBL] [Abstract][Full Text] [Related]
11. Anti-dengue infectivity evaluation of bioflavonoid from
Dwivedi VD; Bharadwaj S; Afroz S; Khan N; Ansari MA; Yadava U; Tripathi RC; Tripathi IP; Mishra SK; Kang SG
J Biomol Struct Dyn; 2021 Mar; 39(4):1417-1430. PubMed ID: 32107969
[TBL] [Abstract][Full Text] [Related]
12. Pharmacophore modeling, molecular docking and molecular dynamics simulation for screening and identifying anti-dengue phytocompounds.
Vora J; Patel S; Athar M; Sinha S; Chhabria MT; Jha PC; Shrivastava N
J Biomol Struct Dyn; 2020 Apr; 38(6):1726-1740. PubMed ID: 31057055
[TBL] [Abstract][Full Text] [Related]
13. A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication.
Pambudi S; Kawashita N; Phanthanawiboon S; Omokoko MD; Masrinoul P; Yamashita A; Limkittikul K; Yasunaga T; Takagi T; Ikuta K; Kurosu T
Biochem Biophys Res Commun; 2013 Oct; 440(3):393-8. PubMed ID: 24070610
[TBL] [Abstract][Full Text] [Related]
14. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
15. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
[TBL] [Abstract][Full Text] [Related]
16. Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents Dengue 2 viral assembly.
Senthilvel P; Lavanya P; Kumar KM; Swetha R; Anitha P; Bag S; Sarveswari S; Vijayakumar V; Ramaiah S; Anbarasu A
Bioinformation; 2013; 9(18):889-95. PubMed ID: 24307765
[TBL] [Abstract][Full Text] [Related]
17. Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus.
Tahir Ul Qamar M; Maryam A; Muneer I; Xing F; Ashfaq UA; Khan FA; Anwar F; Geesi MH; Khalid RR; Rauf SA; Siddiqi AR
Sci Rep; 2019 Feb; 9(1):1433. PubMed ID: 30723263
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential ZIKV NS2B-NS3 protease inhibitors from
Thirumoorthy G; Tarachand SP; Nagella P; Veerappa Lakshmaiah V
J Biomol Struct Dyn; 2022; 40(21):11203-11215. PubMed ID: 34319220
[No Abstract] [Full Text] [Related]
19. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
20.
Shill DK; Jahan S; Alam MM; Limon MBH; Alam M; Rahman MZ; Rahman M
Bioinform Biol Insights; 2023; 17():11779322231158249. PubMed ID: 36873305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
